Related Experiment Videos

Urinary oxalate excretion by very low birth weight infants receiving parenteral nutrition

T Campfield1, G Braden

  • 1Department of Pediatrics and Medicine, Baystate Medical Center, Springfield, Massachusetts 01199.

Pediatrics
|November 1, 1989
PubMed

Insights

Total parenteral nutrition (TPN) in very low birth weight (VLBW) infants is linked to higher urinary oxalate levels. This may contribute to kidney calcifications, a concern in VLBW infants receiving TPN.

Area of Science:

  • Neonatal Medicine
  • Pediatric Nephrology
  • Biochemistry

Background:

  • Renal calcifications are observed in very low birth weight (VLBW) infants, with diuretic-induced hypercalciuria implicated in their development.
  • Hyperoxaluria is a known risk factor for renal stone formation in pediatric and adult populations.
  • Parenteral nutrition (PN) solutions contain oxalate precursors, namely ascorbate and glycine, raising questions about their impact on oxalate excretion in infants.

Purpose of the Study:

  • To investigate the association between total parenteral nutrition (TPN) administration and oxalate excretion in VLBW infants.
  • To determine if varying protein levels in TPN influence urinary oxalate concentrations in this vulnerable population.

Main Methods:

  • Comparison of urinary oxalate concentration and oxalate to creatinine ratio in VLBW infants receiving different nutritional regimens.
  • Inclusion of VLBW infants receiving TPN (0.5 g/kg/day and 1.5 g/kg/day protein) and those receiving glucose/electrolyte solutions.

Main Results:

  • VLBW infants receiving TPN (0.5 g/kg/day protein) showed increased urinary oxalate concentration and oxalate to creatinine ratio compared to controls.
  • A further elevation in urinary oxalate levels was observed in VLBW infants receiving higher protein TPN (1.5 g/kg/day).

Conclusions:

  • Elevated urinary oxalate concentrations can occur in VLBW infants receiving TPN.
  • Increased oxalate excretion associated with TPN may be a contributing factor to nephrocalcinosis in VLBW infants.

Related Concept Videos